Central subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathy

Background To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR). Methods Cross sectional study including consecutive patie...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of retina and vitreous Vol. 4; no. 1; pp. 41 - 5
Main Authors Ahuja, Sukriti, Saxena, Sandeep, Meyer, Carsten H., Gilhotra, Jagjit S., Akduman, Levent
Format Journal Article
LanguageEnglish
Published London BioMed Central 02.11.2018
BMC
Subjects
Online AccessGet full text
ISSN2056-9920
2056-9920
DOI10.1186/s40942-018-0144-9

Cover

Abstract Background To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR). Methods Cross sectional study including consecutive patients of type 2 diabetes mellitus [without DR (No DR, n = 97); non-proliferative DR (NPDR, n = 91); proliferative DR (PDR, n = 83)] and healthy controls (n = 82) was undertaken. CST and CAT values were measured using SD-OCT. Data was analyzed using Chi square test, ANOVA and multivariate analysis. Discriminant values of CST and CAT for EZ disruption were evaluated using receiver operator characteristic curve. Area under curve (AUC) was computed. Results Mean CAT and CST values in the study subjects showed an incremental trend. Multivariate ordinal logistic regression analysis showed increase in CST (OR = 1.022, p < 0.001) and CAT (OR = 1.029, p < 0.001) as significant independent predictors of EZ disruption. Area under curve showed excellent predictive results of CST (AUC = 0. 943 ± 0.021, 95% CI, 0.902–0.984, p < 0.05) and CAT (AUC = 0.959 ± 0.012, 95% CI 0.936–0.982, p < 0.05), as bioimaging biomarkers, for EZ disruption. Conclusion Increase in CST and CAT is associated with increased odds of EZ disruption and these macular parameters serve as bioimaging biomarkers for EZ disruption in DR.
AbstractList Background To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR). Methods Cross sectional study including consecutive patients of type 2 diabetes mellitus [without DR (No DR, n = 97); non-proliferative DR (NPDR, n = 91); proliferative DR (PDR, n = 83)] and healthy controls (n = 82) was undertaken. CST and CAT values were measured using SD-OCT. Data was analyzed using Chi square test, ANOVA and multivariate analysis. Discriminant values of CST and CAT for EZ disruption were evaluated using receiver operator characteristic curve. Area under curve (AUC) was computed. Results Mean CAT and CST values in the study subjects showed an incremental trend. Multivariate ordinal logistic regression analysis showed increase in CST (OR = 1.022, p < 0.001) and CAT (OR = 1.029, p < 0.001) as significant independent predictors of EZ disruption. Area under curve showed excellent predictive results of CST (AUC = 0. 943 ± 0.021, 95% CI, 0.902–0.984, p < 0.05) and CAT (AUC = 0.959 ± 0.012, 95% CI 0.936–0.982, p < 0.05), as bioimaging biomarkers, for EZ disruption. Conclusion Increase in CST and CAT is associated with increased odds of EZ disruption and these macular parameters serve as bioimaging biomarkers for EZ disruption in DR.
Background To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR). Methods Cross sectional study including consecutive patients of type 2 diabetes mellitus [without DR (No DR, n = 97); non-proliferative DR (NPDR, n = 91); proliferative DR (PDR, n = 83)] and healthy controls (n = 82) was undertaken. CST and CAT values were measured using SD-OCT. Data was analyzed using Chi square test, ANOVA and multivariate analysis. Discriminant values of CST and CAT for EZ disruption were evaluated using receiver operator characteristic curve. Area under curve (AUC) was computed. Results Mean CAT and CST values in the study subjects showed an incremental trend. Multivariate ordinal logistic regression analysis showed increase in CST (OR = 1.022, p < 0.001) and CAT (OR = 1.029, p < 0.001) as significant independent predictors of EZ disruption. Area under curve showed excellent predictive results of CST (AUC = 0. 943 ± 0.021, 95% CI, 0.902–0.984, p < 0.05) and CAT (AUC = 0.959 ± 0.012, 95% CI 0.936–0.982, p < 0.05), as bioimaging biomarkers, for EZ disruption. Conclusion Increase in CST and CAT is associated with increased odds of EZ disruption and these macular parameters serve as bioimaging biomarkers for EZ disruption in DR.
To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR). Cross sectional study including consecutive patients of type 2 diabetes mellitus [without DR (No DR, n = 97); non-proliferative DR (NPDR, n = 91); proliferative DR (PDR, n = 83)] and healthy controls (n = 82) was undertaken. CST and CAT values were measured using SD-OCT. Data was analyzed using Chi square test, ANOVA and multivariate analysis. Discriminant values of CST and CAT for EZ disruption were evaluated using receiver operator characteristic curve. Area under curve (AUC) was computed. Mean CAT and CST values in the study subjects showed an incremental trend. Multivariate ordinal logistic regression analysis showed increase in CST (OR = 1.022, p < 0.001) and CAT (OR = 1.029, p < 0.001) as significant independent predictors of EZ disruption. Area under curve showed excellent predictive results of CST (AUC = 0. 943 ± 0.021, 95% CI, 0.902-0.984, p < 0.05) and CAT (AUC = 0.959 ± 0.012, 95% CI 0.936-0.982, p < 0.05), as bioimaging biomarkers, for EZ disruption. Increase in CST and CAT is associated with increased odds of EZ disruption and these macular parameters serve as bioimaging biomarkers for EZ disruption in DR.
Abstract Background To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR). Methods Cross sectional study including consecutive patients of type 2 diabetes mellitus [without DR (No DR, n = 97); non-proliferative DR (NPDR, n = 91); proliferative DR (PDR, n = 83)] and healthy controls (n = 82) was undertaken. CST and CAT values were measured using SD-OCT. Data was analyzed using Chi square test, ANOVA and multivariate analysis. Discriminant values of CST and CAT for EZ disruption were evaluated using receiver operator characteristic curve. Area under curve (AUC) was computed. Results Mean CAT and CST values in the study subjects showed an incremental trend. Multivariate ordinal logistic regression analysis showed increase in CST (OR = 1.022, p < 0.001) and CAT (OR = 1.029, p < 0.001) as significant independent predictors of EZ disruption. Area under curve showed excellent predictive results of CST (AUC = 0. 943 ± 0.021, 95% CI, 0.902–0.984, p < 0.05) and CAT (AUC = 0.959 ± 0.012, 95% CI 0.936–0.982, p < 0.05), as bioimaging biomarkers, for EZ disruption. Conclusion Increase in CST and CAT is associated with increased odds of EZ disruption and these macular parameters serve as bioimaging biomarkers for EZ disruption in DR.
To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR).BACKGROUNDTo evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR).Cross sectional study including consecutive patients of type 2 diabetes mellitus [without DR (No DR, n = 97); non-proliferative DR (NPDR, n = 91); proliferative DR (PDR, n = 83)] and healthy controls (n = 82) was undertaken. CST and CAT values were measured using SD-OCT. Data was analyzed using Chi square test, ANOVA and multivariate analysis. Discriminant values of CST and CAT for EZ disruption were evaluated using receiver operator characteristic curve. Area under curve (AUC) was computed.METHODSCross sectional study including consecutive patients of type 2 diabetes mellitus [without DR (No DR, n = 97); non-proliferative DR (NPDR, n = 91); proliferative DR (PDR, n = 83)] and healthy controls (n = 82) was undertaken. CST and CAT values were measured using SD-OCT. Data was analyzed using Chi square test, ANOVA and multivariate analysis. Discriminant values of CST and CAT for EZ disruption were evaluated using receiver operator characteristic curve. Area under curve (AUC) was computed.Mean CAT and CST values in the study subjects showed an incremental trend. Multivariate ordinal logistic regression analysis showed increase in CST (OR = 1.022, p < 0.001) and CAT (OR = 1.029, p < 0.001) as significant independent predictors of EZ disruption. Area under curve showed excellent predictive results of CST (AUC = 0. 943 ± 0.021, 95% CI, 0.902-0.984, p < 0.05) and CAT (AUC = 0.959 ± 0.012, 95% CI 0.936-0.982, p < 0.05), as bioimaging biomarkers, for EZ disruption.RESULTSMean CAT and CST values in the study subjects showed an incremental trend. Multivariate ordinal logistic regression analysis showed increase in CST (OR = 1.022, p < 0.001) and CAT (OR = 1.029, p < 0.001) as significant independent predictors of EZ disruption. Area under curve showed excellent predictive results of CST (AUC = 0. 943 ± 0.021, 95% CI, 0.902-0.984, p < 0.05) and CAT (AUC = 0.959 ± 0.012, 95% CI 0.936-0.982, p < 0.05), as bioimaging biomarkers, for EZ disruption.Increase in CST and CAT is associated with increased odds of EZ disruption and these macular parameters serve as bioimaging biomarkers for EZ disruption in DR.CONCLUSIONIncrease in CST and CAT is associated with increased odds of EZ disruption and these macular parameters serve as bioimaging biomarkers for EZ disruption in DR.
ArticleNumber 41
Author Ahuja, Sukriti
Meyer, Carsten H.
Akduman, Levent
Gilhotra, Jagjit S.
Saxena, Sandeep
Author_xml – sequence: 1
  givenname: Sukriti
  surname: Ahuja
  fullname: Ahuja, Sukriti
  organization: Department of Ophthalmology, King George’s Medical University
– sequence: 2
  givenname: Sandeep
  surname: Saxena
  fullname: Saxena, Sandeep
  email: sandeepsaxena2020@yahoo.com
  organization: Department of Ophthalmology, King George’s Medical University
– sequence: 3
  givenname: Carsten H.
  surname: Meyer
  fullname: Meyer, Carsten H.
  organization: Department of Ophthalmology, Pallas Klinik
– sequence: 4
  givenname: Jagjit S.
  surname: Gilhotra
  fullname: Gilhotra, Jagjit S.
  organization: Department of Ophthalmology, University of Adelaide
– sequence: 5
  givenname: Levent
  surname: Akduman
  fullname: Akduman, Levent
  organization: Department of Ophthalmology, Saint Louis University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30410791$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1v1DAQjVARLaU_gAuyxIVLwOPEcXxBQhUflSpxgbPlOOOst1l7sZNK7ZkfjkNa2FaCg-3x-L3np5l5Xhz54LEoXgJ9C9A271JNZc1KCm1edV3KJ8UJo7wppWT06CA-Ls5S2lJKoeEATf2sOK5oDVRIOCl-nqOfoh5JmjvrcOzJtHHmymNKRPuemLlDoq8x6gEPnxLpXHA7PTg_LOFOxyuMidgQCY6j26fgenKbLZPepTjvJxc8cT7fdIeTMyTm3Ye9njY3L4qnVo8Jz-7O0-L7p4_fzr-Ul18_X5x_uCwNh1aWIFuUreBoW90AQ8E15bbXXFgDUtcWTVUZaSsqBOUdAtOyQxRWVAIyrTotLlbdPuit2sfsP96ooJ36nQhxUDpmbyMqBtzqjoGoUNfUNLrBntJetKKxLOez1vtVaz93O-zNWsYHog9fvNuoIVyrhkENnGeBN3cCMfyYMU1q55LJtdMew5yyg4oxDpIvf71-BN2GOfpcqgXFoWaCLqhXh47-WLlvdgaIFWBiSCmiVcZNemlMNuhGBVQtk6XWyVJ5stQyWUpmJjxi3ov_j8NWTspYP2D8a_rfpF9YBOI2
CitedBy_id crossref_primary_10_1016_j_jcjo_2024_12_006
crossref_primary_10_1007_s12020_019_02093_7
crossref_primary_10_1007_s00417_020_05039_2
crossref_primary_10_1080_08164622_2021_1896333
crossref_primary_10_1097_IAE_0000000000003473
crossref_primary_10_1007_s10792_021_01941_8
crossref_primary_10_1080_16089677_2021_1903170
crossref_primary_10_1038_s41433_024_03172_4
crossref_primary_10_1038_s41598_024_82007_4
Cites_doi 10.1371/journal.pone.0081600
10.1186/2045-3701-4-27
10.1016/S0161-6420(13)38012-9
10.1016/j.survophthal.2008.10.001
10.1016/S0140-6736(09)62124-3
10.4103/0974-7788.59946
10.1016/j.jdiacomp.2016.01.010
10.1111/ceo.12506
10.1016/j.oret.2017.02.002
10.1186/s40662-015-0026-2
10.1016/j.ophtha.2006.10.055
10.1167/iovs.08-2970
10.1167/iovs.10-6518
10.2337/dc14-S081
10.1016/j.exer.2013.07.018
10.1016/j.jdiacomp.2015.12.009
10.1038/srep39161
10.1016/j.ajo.2009.08.037
10.2337/db07-0982
10.1186/s40942-016-0033-z
ContentType Journal Article
Copyright The Author(s) 2018
Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2018
– notice: Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s40942-018-0144-9
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection (Proquest)
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X7
  name: Proquest Health and Medical Complete
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2056-9920
EndPage 5
ExternalDocumentID oai_doaj_org_article_215fab2173ea40c6a6ed00d7876f2b21
PMC6214155
30410791
10_1186_s40942_018_0144_9
Genre Journal Article
GroupedDBID 0R~
53G
5VS
7X7
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABUWG
ACGFS
ADBBV
ADRAZ
ADUKV
AFKRA
AFPKN
AHBYD
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
ASPBG
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EJD
FYUFA
GROUPED_DOAJ
H13
HMCUK
HYE
IAO
IEA
IHR
IHW
ITC
KQ8
M48
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PUEGO
RBZ
ROL
RPM
RSV
SOJ
UKHRP
AAYXX
CITATION
3V.
ACRMQ
ADINQ
AHSBF
C24
EMOBN
NPM
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c5189-198e9875ef8a612e75a05fda57fc19a4fec33c9f307705be12a9bee7f737175e3
IEDL.DBID M48
ISSN 2056-9920
IngestDate Wed Aug 27 01:31:24 EDT 2025
Thu Aug 21 14:24:46 EDT 2025
Thu Sep 04 21:56:50 EDT 2025
Mon Jun 30 04:46:34 EDT 2025
Thu Jan 02 22:55:55 EST 2025
Thu Apr 24 23:10:08 EDT 2025
Tue Jul 01 04:38:08 EDT 2025
Sat Sep 06 07:27:55 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Spectral domain optical coherence tomography
Central subfield thickness
Diabetic retinopathy
Biomarker
Receiver operator characteristic curve
Ellipsoid zone
Cube average thickness
Area under curve
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5189-198e9875ef8a612e75a05fda57fc19a4fec33c9f307705be12a9bee7f737175e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s40942-018-0144-9
PMID 30410791
PQID 2135142701
PQPubID 2040226
PageCount 5
ParticipantIDs doaj_primary_oai_doaj_org_article_215fab2173ea40c6a6ed00d7876f2b21
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6214155
proquest_miscellaneous_2132251951
proquest_journals_2135142701
pubmed_primary_30410791
crossref_citationtrail_10_1186_s40942_018_0144_9
crossref_primary_10_1186_s40942_018_0144_9
springer_journals_10_1186_s40942_018_0144_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20181102
PublicationDateYYYYMMDD 2018-11-02
PublicationDate_xml – month: 11
  year: 2018
  text: 20181102
  day: 2
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle International journal of retina and vitreous
PublicationTitleAbbrev Int J Retin Vitr
PublicationTitleAlternate Int J Retina Vitreous
PublicationYear 2018
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References N Mishra (144_CR24) 2015; 30
X Zhang (144_CR15) 2008; 57
HL Deissler (144_CR16) 2013; 115
S Omri (144_CR19) 2013; 8
S Ruia (144_CR7) 2016; 2
S Sharma (144_CR22) 2015; 43
N Bhagat (144_CR14) 2009; 54
American Diabetes Association (144_CR10) 2014; 37
J Cunha-Vaz (144_CR20) 2017; 1
Xu Hui-Zhuo (144_CR18) 2011; 52
N Cheung (144_CR2) 2010; 376
UEK Wolf-Schnurrbusch (144_CR12) 2009; 50
R Lee (144_CR1) 2015; 2
A Jain (144_CR6) 2013; 19
S Sinha (144_CR23) 2016; 30
SR Sharma (144_CR5) 2014; 2
P Kadam (144_CR9) 2010; 1
ETDRS Research Group (144_CR11) 1991; 98
W Li (144_CR17) 2013; 54
DF Kiernan (144_CR4) 2010; 149
144_CR13
X Zhang (144_CR3) 2014; 4
Diabetic Retinopathy Clinical Research Network (144_CR8) 2007; 114
Y Mori (144_CR25) 2016; 6
A Jain (144_CR21) 2013; 19
References_xml – volume: 19
  start-page: 1760
  year: 2013
  ident: 144_CR21
  publication-title: Mol Vis
– ident: 144_CR13
– volume: 8
  start-page: e81600
  issue: 11
  year: 2013
  ident: 144_CR19
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0081600
– volume: 4
  start-page: 27
  year: 2014
  ident: 144_CR3
  publication-title: Cell Biosci
  doi: 10.1186/2045-3701-4-27
– volume: 98
  start-page: 786
  year: 1991
  ident: 144_CR11
  publication-title: Ophthalmol
  doi: 10.1016/S0161-6420(13)38012-9
– volume: 54
  start-page: 1
  issue: 1
  year: 2009
  ident: 144_CR14
  publication-title: Surv Ophthalmol
  doi: 10.1016/j.survophthal.2008.10.001
– volume: 376
  start-page: 124
  issue: 9735
  year: 2010
  ident: 144_CR2
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)62124-3
– volume: 1
  start-page: 55
  issue: 1
  year: 2010
  ident: 144_CR9
  publication-title: Int J Ayurveda Res
  doi: 10.4103/0974-7788.59946
– volume: 30
  start-page: 700
  year: 2016
  ident: 144_CR23
  publication-title: J Diabetes Complicat
  doi: 10.1016/j.jdiacomp.2016.01.010
– volume: 43
  start-page: 429
  year: 2015
  ident: 144_CR22
  publication-title: Clin Exp Ophthalmol.
  doi: 10.1111/ceo.12506
– volume: 1
  start-page: 395
  year: 2017
  ident: 144_CR20
  publication-title: Ophthalmol Retina.
  doi: 10.1016/j.oret.2017.02.002
– volume: 2
  start-page: 17
  year: 2015
  ident: 144_CR1
  publication-title: Eye Vis
  doi: 10.1186/s40662-015-0026-2
– volume: 114
  start-page: 1520
  issue: 8
  year: 2007
  ident: 144_CR8
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2006.10.055
– volume: 19
  start-page: 1760
  year: 2013
  ident: 144_CR6
  publication-title: Mol Vis.
– volume: 50
  start-page: 3432
  issue: 7
  year: 2009
  ident: 144_CR12
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.08-2970
– volume: 52
  start-page: 2160
  issue: 5
  year: 2011
  ident: 144_CR18
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.10-6518
– volume: 37
  start-page: S81
  year: 2014
  ident: 144_CR10
  publication-title: Diabetes Care
  doi: 10.2337/dc14-S081
– volume: 115
  start-page: 162
  year: 2013
  ident: 144_CR16
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2013.07.018
– volume: 54
  start-page: 219
  issue: 15
  year: 2013
  ident: 144_CR17
  publication-title: Invest Ophthalmol Vis Sci
– volume: 30
  start-page: 511
  year: 2015
  ident: 144_CR24
  publication-title: J Diabetes Complicat
  doi: 10.1016/j.jdiacomp.2015.12.009
– volume: 6
  start-page: 39161
  year: 2016
  ident: 144_CR25
  publication-title: Sci Rep
  doi: 10.1038/srep39161
– volume: 149
  start-page: 18
  year: 2010
  ident: 144_CR4
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2009.08.037
– volume: 2
  start-page: 502
  issue: 5
  year: 2014
  ident: 144_CR5
  publication-title: J Case Rep Stud.
– volume: 57
  start-page: 1026
  issue: 4
  year: 2008
  ident: 144_CR15
  publication-title: Diabetes
  doi: 10.2337/db07-0982
– volume: 2
  start-page: 1
  year: 2016
  ident: 144_CR7
  publication-title: Int J Retina Vitreous.
  doi: 10.1186/s40942-016-0033-z
SSID ssj0001651164
Score 2.0978234
Snippet Background To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral...
To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical...
Background To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral...
Abstract Background To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 41
SubjectTerms Biomarker
Biomarkers
Central subfield thickness
Cube average thickness
Diabetes
Diabetic retinopathy
Edema
Ellipsoid zone
Glucose
Medical imaging
Medicine
Medicine & Public Health
Multivariate analysis
Ophthalmology
Original
Original Article
Oxidative stress
Retina
Spectral domain optical coherence tomography
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1Ni9UwMMgexIv47dNVInhSyqZpPo8qLouwnlzYW0mTKRbddnndHvTsD3cm7Xu-5-fFW-lMy5CZJPM9jD0PVjTSkwsMSlkob0LhdBsLKKNMUbpWNlQofPrenJypd-f6fGfUF-WEze2B54U7wiupDQ0qzhUEJaIJBpIQCeXM4H9yCbkUXuwYU9m7YlCRMGoJY5bOHI1kyFAWAuVuKVX4vYso9-v_nZL5a67kTwHTfA8d32I3FwWSv5oJv82uQX-HXT9dQuR32bfFX8vHqcnpaZwy2j_RicZDn3icGuABBRgPkl3QyJtu6C7y0CJ6vKC8nfXIUanlkAMGQ5f416EHnrpxPeWjhnc9n723XeRUD9kPNOL4yz12dvz2w5uTYhm1UERdOl-U3oFH0wVaF1DnAauD0G0K2rax9EG1EKsq-hZPBCt0g3wNvgGwra3QHtRQ3WcHPVLwkHERbQDjATG9ilY4mxwkEMapmIQOKyY2617HpQ85jcP4XGd7xJl6ZlWNrKqJVbVfsRfbTy7nJhx_Q35NzNwiUv_s_AKlql6kqv6XVK3Y4UYU6mVTj_gRlT1IKxD8bAvG7UgxltDDMGUcScXAGnEezJKzpaQSCo1tjxC7J1N7pO5D-u5jbvltZEma34q93EjfD7L-uBKP_sdKPGY3JG0a8qTLQ3ZwtZ7gCephV83TvOW-AzWCMGo
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection (Proquest)
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LbtQw0IIiIS6IN4GCjMQJFNVxHDs-IUBUFVI5UWlvkWNPIIImZdMc2jMfzozXu8vy6C2KJ9LE8_C8PMPYS2dEKy2FwKCQubLa5XXV-RwKL4OXdSdbuih8_EkfnaiPi2qRAm5TKqtc68SoqMPoKUZ-IGmUnJJGFG_OfuQ0NYqyq2mExnV2I7YuQ342C7ONsWg0J7RKycyi1gcTuTNUi0AVXErlduc4il37_2Vq_l0x-UfaNJ5Gh3fY7WRG8rcrut9l12C4x24ep0T5ffYzRW35NLexSI1TXfs30mvcDYH7uQXukI1Rnfy-NPG2H_vTOLqIHk-pemc5cTRtOcS0wdgHfjkOwEM_LeeocHg_8FUMt_ecbkUOIw06vnjATg4_fH5_lKeBC7mvitrmha3BogMDXe3Q8gFTOVF1wVWm84V1qgNflt52qBeMqFqkrrMtgOlMiV5hBeVDtjcgBo8ZF9440BYQ0ipvRG1CDQGErpUPonIZE-t9b3zqRk5DMb430SupdbMiVYOkaohUjc3Yq80nZ6tWHFcBvyNibgCpi3Z8MS6_NEkoGzR3OteiU1aCU8JrpyEIEVCHaeRRWWRsf80KTRLtqdkyYsZebJZRKCnT4gYY5wgj6UpwhTCPVpyzwaQUCl1uiytmh6d2UN1dGfqvsfG3lgXZfxl7vea-LVr_3YknV__EU3ZLkjhQpFzus73z5QzP0M46b59HYfoFMdAn2g
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1Ni9UwMOgK4kX89ukqETwpxTTN51EXl0VYTy7sraTJFItuK6_bg5794c6kfW_36Sp4K50JhMxH5juMvQxWNNJTCAxKWShvQuF0Gwsoo0xRulY21Ch8_NEcnagPp_p0GRZNvTCX8_elM29G8j-oeIBKrpQq_HV2Q5eVyXlZc3ARTjFoORi15C2vXLlz8-QB_VdZlX8WR_6WIc0Xz-EddnuxGPnbmcR32TXo77Gbx0tO_D77uQRo-Tg1uR6NUwn7F1JhPPSJx6kBHpBjUXNcBo286YbuLL9SRJ9nVKizHjlasRxyhmDoEv8x9MBTN66nrFt41_M5XNtFTg2Q_UBvGn9_wE4O3386OCqWtxWKqEvni9I78OirQOsCGjlgdRC6TUHbNpY-qBZiVUXfogqwQjdIyOAbANvaCh1ADdVDttfjDh4zLqINYDwgplfRCmeTgwTCOBWT0GHFxObc67gMHqf3L77W2QFxpp5JVSOpaiJV7Vfs1XbJt3nqxr-Q3xExt4g0MDv_QD6qF_mr0bJpQ4P-VwVBiWiCgSREQnVlkB1luWL7G1aoFykecRH1OUgrEPxiC0b5o6RK6GGYMo6k7l-NOI9mztnupBIKvWuPELvDUztb3YX03ec849vIkky9FXu94b6Lbf31JJ78F_ZTdkuSdFCMXO6zvfP1BM_QwjpvnmfZ-gXm-SB0
  priority: 102
  providerName: Springer Nature
Title Central subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathy
URI https://link.springer.com/article/10.1186/s40942-018-0144-9
https://www.ncbi.nlm.nih.gov/pubmed/30410791
https://www.proquest.com/docview/2135142701
https://www.proquest.com/docview/2132251951
https://pubmed.ncbi.nlm.nih.gov/PMC6214155
https://doaj.org/article/215fab2173ea40c6a6ed00d7876f2b21
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1db9Mw0NqHNO0F8U1hVEbiCRRw3MSOHxDqqk1TpU4IqNS3yHEuELEl0KwS45kfzp2TFAqFB54SxWfF8n34vnzH2FOrRSYNucAglEFklA2SuHABhE7mTiaFzOii8Oxcnc2j6SJe7LC-vVW3gc1W0476Sc2XFy--frl-jQz_yjN8ol42ZKNQggGlZUVRYHbZPh5MimyxWafte5eLQu1CRV1sc-vMQ3aA9j2aRCbcOKh8Pf9tSuifuZS_BVT9OXV6k93oFEw-biniFtuB6jY7mHUh9Dvse-fP5c0q8-lrnDLeP5HE47bKuVtlwC0SOAqaX4canpV1eembGtHrJeX1LBuOSi8HH1Coy5x_qyvgedksV14U8bLirXe3dJzuS1Y1tUC-vsvmpyfvJ2dB14ohcHGYmCA0CRg0baBILOpEoGMr4iK3sS5caGxUgBuNnClQYmgRZ4h3azIAXegR2osxjO6xvQpX8IBx4bQFZQAhTeS0SHSeQA5CJZHLRWwHTPT7nrquTjm1y7hIvb2SqLTFWopYSwlrqRmwZ-spn9siHf8CPiZkrgGpvrb_UC8_pB27pqgIFTZDc20ENhJOWQW5EDlKN4XUK8MBO-pJIe1pFifRtQipBQ4_WQ8ju1IMxlZQrzyMpMvCMcLcbylnvZKe8gZMb9DUxlI3R6ryoy8JrmRImuGAPe-p7-ey_roTD__7P4_YoSSmIfe6PGJ7V8sVPEbl7Cobsl290EO2Px5P303xeXxy_uYtfp2oydA7PIaeKX8AjTk-HA
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVAIuiDeBAosEF5DV9Xof3gNCFFqltIkQaqXe3PV6Ta1Su8SNUDnze_iNzPiREB699RZlJ9HaM_PtPHcIeW41S7nBEJgPeSCMskEscxf40PHM8TjnKTYKjydqtC8-HMiDFfKz74XBssoeExugziqHMfJ1jqPkBNcsfHP6NcCpUZhd7UdotGKx48-_gctWv95-D_x9wfnW5t67UdBNFQicDGMTgJftwdGWPo8tHO9eS8tknlmpcxcaK3LvosiZHIRfM5nCI1iTeq9zHYHrI30E_3uFrArsaB2Q1Y3NycdPi6iOAgNGiS59GsZqvUYHCqsfsGZMiMAsHYDNnIB_Gbd_12j-kahtzr-tm-RGZ7jSt62k3SIrvrxNro671Pwd8qOLE9N6ljZlcRQr6Y8RSaktM-pmqacWFAcA7PelmqZFVZw0w5Lw4wnWC01rCsY09U2ioioy-r0qPc2KejprII4WJW2jxoWj2IdZVjha-fwu2b8UZtwjgxJ28IBQ5rT1ynigNMJpFuss9plnKhYuY9IOCevfe-K6-89xDMeXpPGDYpW0rEqAVQmyKjFD8nL-k9P28o-LiDeQmXNCvLe7-aKafk46GEjAwMptCm5g5K1gTlnlM8YyQE0FWsHDIVnrRSHpwKROFqI_JM_mywADmNuxpa9mDQ3HJmQJNPdbyZnvJGICnHwDK3pJppa2urxSFkfNVeOKh2hxDsmrXvoW2_rvm3h48UM8JddGe-PdZHd7svOIXOeoGhin52tkcDad-cdg5Z2lTzrVouTwsrX5FwI4Zhk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3LbtQw0IIiVVwQb7YUMBInUFTHcez4CIVVebTiQKXeIseeQARNqs3mUM58ODNOdstCQeK22hlLVubheQ9jz5wRlbQUAoNUJspqlxR57RNIvQxeFrWsqFH48EgfHKt3J_nJtOe0X1W7r1KSY08DTWlql3tnoR5FvNB7PXklVFJAhVhKJfYqu6bo5aNsrd6_CLJotCe0mrKZl57ceI_i2P7LbM0_SyZ_y5vG52h-k92Y7Ej-ciT8LXYF2tts-3DKlN9hP6awLe-HKlapcSps_0qKjbs2cD9UwB3yMeqTX0E9r5quOY27i-jnKZXvLHqOti2HmDfomsC_dy3w0PSLIWoc3rR8DOI2nlNbZNvRpuPzu-x4_ubT_kEybVxIfJ4WNkltARY9GKgLh6YPmNyJvA4uN7VPrVM1-CzztkbFYEReIXmdrQBMbTJ0C3PI7rGtFm_wgHHhjQNtATGt8kYUJhQQQOhC-SByN2Ni9d1LP40jp60Y38rolhS6HElVIqlKIlVpZ-z5-sjZOIvjX8iviJhrRBqjHf_oFp_LSSpLtHdqV6FXloFTwmunIQgRUIlpZFKZztjuihXKSbZ7PETdD9IIBD9dg1EqKdXiWuiGiCOpJzhHnPsj56xvkgmFPrdFiNngqY2rbkLa5kuc_K1lSgbgjL1Ycd_Ftf76JXb-C_sJ2_74el5-eHv0_iG7LklQKIgud9nWcjHAIzTBltXjKGY_ASifK6g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Central+subfield+thickness+and+cube+average+thickness+as+bioimaging+biomarkers+for+ellipsoid+zone+disruption+in+diabetic+retinopathy&rft.jtitle=International+journal+of+retina+and+vitreous&rft.au=Ahuja%2C+Sukriti&rft.au=Saxena%2C+Sandeep&rft.au=Meyer%2C+Carsten+H.&rft.au=Gilhotra%2C+Jagjit+S.&rft.date=2018-11-02&rft.pub=BioMed+Central&rft.eissn=2056-9920&rft.volume=4&rft_id=info:doi/10.1186%2Fs40942-018-0144-9&rft_id=info%3Apmid%2F30410791&rft.externalDocID=PMC6214155
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2056-9920&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2056-9920&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2056-9920&client=summon